Compare ALT & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALT | KOPN |
|---|---|---|
| Founded | 1997 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 424.9M |
| IPO Year | 2005 | 2025 |
| Metric | ALT | KOPN |
|---|---|---|
| Price | $3.53 | $2.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $16.00 | $4.25 |
| AVG Volume (30 Days) | ★ 2.6M | 2.1M |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,000.00 | ★ $1,044,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $45.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.91 | $0.71 |
| 52 Week High | $7.73 | $4.16 |
| Indicator | ALT | KOPN |
|---|---|---|
| Relative Strength Index (RSI) | 29.33 | 45.79 |
| Support Level | $3.39 | $2.24 |
| Resistance Level | $4.25 | $2.58 |
| Average True Range (ATR) | 0.22 | 0.14 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 0.53 | 52.63 |
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.